• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

围手术期体成分异常对劈离式肝移植术后结局的不良影响:一项多中心回顾性队列研究。

The adverse impact of perioperative body composition abnormalities on outcomes after split liver transplantation: a multicenter retrospective cohort study.

机构信息

Zhejiang University, School of Medicine.

Key Laboratory of Combined Multi-organ Transplantation, Ministry of Public Health.

出版信息

Int J Surg. 2024 Jun 1;110(6):3543-3553. doi: 10.1097/JS9.0000000000001303.

DOI:10.1097/JS9.0000000000001303
PMID:38489552
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11175784/
Abstract

BACKGROUND

Split liver transplantation (SLT) increases graft availability, but it's safe and effective utilization is insufficiently documented. This study aimed to investigate the association between perioperative body composition abnormalities and outcomes in adult SLT.

MATERIALS AND METHODS

Two hundred forty recipients who underwent SLT in three centers were enrolled in this retrospective cohort study. Body composition abnormalities including sarcopenia, myosteatosis, visceral obesity, and sarcopenic obesity were evaluated at baseline and 1 month after surgery using computed tomography. Their impact on outcomes including early allograft dysfunction, early complications, ICU stay, graft regeneration rate, and survival was analyzed.

RESULTS

Recipients with sarcopenia or myosteatosis had a higher risk of early allograft dysfunction, higher early complication rate, and longer length of ICU stay (all P <0.05), while there was no difference in graft regeneration rate. Recipient and graft survival were significantly worse for recipients with body composition abnormalities (all P <0.05). In multivariable Cox-regression analysis, sarcopenia [hazard ratio (HR)=1.765, P =0.015], myosteatosis (HR=2.066, P =0.002), and visceral obesity (HR=1.863, P =0.008) were independently associated with shorter overall survival. Piling up of the three factors increased the mortality risk stepwise ( P <0.001). Recipients experienced skeletal muscle loss and muscle fat infiltration 1 month after surgery. Postoperative worsening sarcopenia (HR=2.359, P =0.009) and myosteatosis (HR=1.878, P =0.026) were also identified as independent risk factors for mortality.

CONCLUSION

Sarcopenia, myosteatosis, and their progression negatively affect outcomes including early allograft dysfunction, early complications, ICU stay and survival after SLT. Systemic evaluation and dynamic monitoring of body composition are valuable.

摘要

背景

劈离式肝移植(SLT)增加了供体的可用性,但它的安全有效利用尚未得到充分记录。本研究旨在探讨成人 SLT 围手术期身体成分异常与结局的关系。

材料和方法

本回顾性队列研究纳入了在三个中心接受 SLT 的 240 例受者。使用计算机断层扫描(CT)在基线和术后 1 个月评估身体成分异常,包括肌肉减少症、肌内脂肪增多、内脏肥胖和肌肉减少性肥胖。分析它们对包括早期移植物功能障碍、早期并发症、重症监护病房(ICU)入住时间、移植物再生率和存活率等结局的影响。

结果

存在肌肉减少症或肌内脂肪增多的受者,早期移植物功能障碍的风险更高,早期并发症发生率更高,ICU 入住时间更长(均 P <0.05),但移植物再生率无差异。存在身体成分异常的受者,受者和移植物存活率明显更差(均 P <0.05)。多变量 Cox 回归分析显示,肌肉减少症(危险比 [HR]=1.765,P =0.015)、肌内脂肪增多(HR=2.066,P =0.002)和内脏肥胖(HR=1.863,P =0.008)与总生存时间缩短独立相关。这三种因素的累积增加了死亡率的递增风险(P <0.001)。受者术后 1 个月经历了骨骼肌丢失和肌肉脂肪浸润。术后恶化的肌肉减少症(HR=2.359,P =0.009)和肌内脂肪增多(HR=1.878,P =0.026)也被确定为死亡的独立危险因素。

结论

肌肉减少症、肌内脂肪增多及其进展对 SLT 后早期移植物功能障碍、早期并发症、ICU 入住时间和存活率等结局产生负面影响。全身评估和身体成分的动态监测具有重要价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a253/11175784/da8077b7cf86/js9-110-3543-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a253/11175784/b1e00ef392b9/js9-110-3543-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a253/11175784/0a28da5c72af/js9-110-3543-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a253/11175784/2ede7daa1231/js9-110-3543-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a253/11175784/da8077b7cf86/js9-110-3543-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a253/11175784/b1e00ef392b9/js9-110-3543-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a253/11175784/0a28da5c72af/js9-110-3543-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a253/11175784/2ede7daa1231/js9-110-3543-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a253/11175784/da8077b7cf86/js9-110-3543-g004.jpg

相似文献

1
The adverse impact of perioperative body composition abnormalities on outcomes after split liver transplantation: a multicenter retrospective cohort study.围手术期体成分异常对劈离式肝移植术后结局的不良影响:一项多中心回顾性队列研究。
Int J Surg. 2024 Jun 1;110(6):3543-3553. doi: 10.1097/JS9.0000000000001303.
2
Sex and gender as predictors for allograft and patient-relevant outcomes after kidney transplantation.性别作为肾移植后同种异体移植及患者相关预后的预测因素。
Cochrane Database Syst Rev. 2024 Dec 19;12(12):CD014966. doi: 10.1002/14651858.CD014966.pub2.
3
Sarcopenia As a Predictor of Survival and Complications of Patients With Cirrhosis After Liver Transplantation: A Systematic Review and Meta-Analysis.肌肉减少症作为肝移植后肝硬化患者生存和并发症的预测指标:一项系统评价和荟萃分析
Clin Transplant. 2025 Feb;39(2):e70088. doi: 10.1111/ctr.70088.
4
[Efficacy and prognostic factors of split liver transplantation from pediatric donors].[小儿供体劈离式肝移植的疗效及预后因素]
Zhonghua Yi Xue Za Zhi. 2025 Jun 24;105(24):1997-2004. doi: 10.3760/cma.j.cn112137-20250206-00255.
5
Different computed tomography parameters for defining myosteatosis in patients with advanced non-small cell lung cancer.用于定义晚期非小细胞肺癌患者肌脂肪变性的不同计算机断层扫描参数。
Clin Nutr. 2023 Dec;42(12):2414-2421. doi: 10.1016/j.clnu.2023.10.006. Epub 2023 Oct 16.
6
What Are the Complications, Function, and Survival of Tumor-devitalized Autografts Used in Patients With Limb-sparing Surgery for Bone and Soft Tissue Tumors? A Japanese Musculoskeletal Oncology Group Multi-institutional Study.肿瘤灭活自体移植物用于保肢手术治疗骨和软组织肿瘤患者的并发症、功能和生存情况如何?日本肌肉骨骼肿瘤学组多机构研究。
Clin Orthop Relat Res. 2023 Nov 1;481(11):2110-2124. doi: 10.1097/CORR.0000000000002720. Epub 2023 Jun 14.
7
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
8
Does Augmenting Irradiated Autografts With Free Vascularized Fibula Graft in Patients With Bone Loss From a Malignant Tumor Achieve Union, Function, and Complication Rate Comparably to Patients Without Bone Loss and Augmentation When Reconstructing Intercalary Resections in the Lower Extremity?对于因恶性肿瘤导致骨缺损的患者,在重建下肢节段性切除时,采用带血管游离腓骨移植来增强照射后的自体骨移植,其骨愈合、功能及并发症发生率与无骨缺损且未进行增强的患者相比是否相当?
Clin Orthop Relat Res. 2025 Jun 26. doi: 10.1097/CORR.0000000000003599.
9
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.静脉注射硫酸镁和索他洛尔预防冠状动脉搭桥术后房颤:系统评价与经济学评估
Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280.
10
Sarcopenia, myosteatosis, and frailty parameters to predict adverse outcomes in patients undergoing emergency laparotomy: prospective observational multicentre cohort study.肌肉减少症、肌少性肥胖和虚弱参数预测急诊剖腹手术患者不良结局的前瞻性观察性多中心队列研究。
BJS Open. 2025 Mar 4;9(2). doi: 10.1093/bjsopen/zraf016.

引用本文的文献

1
A nomogram model based on CT-assessed body composition parameters for predicting postoperative recurrence in advanced gastric cancer.基于CT评估的身体成分参数预测进展期胃癌术后复发的列线图模型。
Abdom Radiol (NY). 2025 Jun 17. doi: 10.1007/s00261-025-05015-6.
2
Impact of myosteatosis on outcomes after liver transplantation: a systematic review and meta-analysis.肌少性肥胖对肝移植术后结局的影响:一项系统评价和荟萃分析
Hepatol Int. 2025 Jun 9. doi: 10.1007/s12072-025-10845-z.
3
Comment on "Myosteatosis and Muscle Loss Impact Liver Transplant Outcomes in Male Patients With Hepatocellular Carcinoma" by Lu et al.-The Authors' Reply.
对Lu等人所著《肌肉脂肪变性和肌肉减少对男性肝细胞癌患者肝移植结局的影响》的评论——作者回复
J Cachexia Sarcopenia Muscle. 2025 Apr;16(2):e13762. doi: 10.1002/jcsm.13762.